Wockhardt to exit US generics business, files for voluntary liquidation of two subsidiaries

Wockhardt has announced a strategic shift in its operations in the United States, deciding to exit the generics pharmaceutical segment in the country. The company has filed for voluntary liquidation under Chapter 7 of the US Bankruptcy Code for its two Delaware-incorporated step-down subsidiaries—Morton Grove Pharmaceuticals Inc. and Wockhardt USA LLC. This move marks a…

Access Denied

Access Denied You don’t have permission to access “http://www.business-standard.com/companies/news/wockhardt-exits-us-generic-pharma-business-files-liquidation-125071101020_1.html” on this server. Reference #18.d1672817.1752237260.a9294b89 https://errors.edgesuite.net/18.d1672817.1752237260.a9294b89 Read the original article here